Parkinson Disease Dementia
23
3
7
9
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
13.0%
3 terminated out of 23 trials
75.0%
-11.5% vs benchmark
9%
2 trials in Phase 3/4
67%
6 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (23)
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
Community Outreach for Palliative Engagement -- Parkinson Disease
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
Parkinson's Disease and Movement Disorders Clinical Database
A Study of Caregiver Connections Via Technology in Dementia
SHARPEN - Parkinson's Disease Dementia
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
Sing for Your Saunter - Dementia Supplement
Innovations in Dementia Empowerment and Action
To Evaluate the Safety of DBS in Patients With Primary Parkinson's Disease
Environmental and Reproductive Health Risk for Lewy Body Dementia
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment
Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?
Comparison Between Parkinson's Disease and Parkinson's Dementia Complex (Genetically,Clinical and Electrophysiological)
Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia